Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.75 is 21% above its 5-year average of 3.11, near the high end of its 5-year range (1.44–4.73).
As of the fiscal period ended Tuesday, March 31, 2026. 9.82% above its 12-month average of 3.42.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-03-31): 3.75.
QUICK RATIO (ACID-TEST)
3.75
QUICK RATIO (ACID-TEST) AVG TTM
3.42
QUICK RATIO (ACID-TEST) AVG 3Y
2.68
QUICK RATIO (ACID-TEST) AVG 5Y
3.11
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+9.82%
CURRENT VS 3Y AVG
+40.34%
CURRENT VS 5Y AVG
+20.85%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+12.06%
vs the sector median at left
Universe Pharmaceuticals Inc.
Market Cap
$2.80M
Quick Ratio (Acid-Test)
3.75
TTM Avg
3.42
3Y Avg
2.68
5Y Avg
3.11
Market Cap
$2.93M
Quick Ratio (Acid-Test)
2.44
TTM Avg
1.83
3Y Avg
3.14
5Y Avg
3.65
Market Cap
$2.93M
Quick Ratio (Acid-Test)
6.21
TTM Avg
4.42
3Y Avg
3.06
5Y Avg
2.22
Market Cap
$3.07M
Quick Ratio (Acid-Test)
1.15
TTM Avg
2.58
3Y Avg
1.43
5Y Avg
2.20
Market Cap
$2.54M
Quick Ratio (Acid-Test)
1.41
TTM Avg
1.72
3Y Avg
3.92
5Y Avg
2.64
Market Cap
$3.14M
Quick Ratio (Acid-Test)
2.35
TTM Avg
1.91
3Y Avg
2.68
5Y Avg
12.13
Market Cap
$2.44M
Quick Ratio (Acid-Test)
0.40
TTM Avg
0.70
3Y Avg
0.81
5Y Avg
0.98
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Universe Pharmaceuticals Inc. (UPC) | $2.80M | 3.75 | 3.42 | 2.68 | 3.11 |
| IceCure Medical Ltd (ICCM)vs › | $2.93M | 2.44 | 1.83 | 3.14 | 3.65 |
| iSpecimen Inc. (ISPC)vs › | $2.69M | 0.82 | 0.87 | 1.93 | 3.50 |
| Revelation Biosciences, Inc. (REVB)vs › | $2.93M | 6.21 | 4.42 | 3.06 | 2.22 |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.07M | 1.15 | 2.58 | 1.43 | 2.20 |
| Nuwellis, Inc. (NUWE)vs › | $2.56M | 1.54 | 1.94 | 2.53 | 3.69 |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.54M | 1.41 | 1.72 | 3.92 | 2.64 |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.14M | 2.35 | 1.91 | 2.68 | 12.13 |
| Jaguar Health, Inc. (JAGX)vs › | $2.44M | 0.40 | 0.70 | 0.81 | 0.98 |
| Onconetix, Inc. (ONCO)vs › | $2.41M | 2.14 | 0.35 | 1.93 | 12.75 |
Quick Ratio
3.75
Excludes inventory
Current Ratio
4.05
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-03-31 | 3.75 |
| 2025-09-30 | 3.90 |
| 2025-03-31 | 2.60 |
| 2024-09-30 | 2.46 |
| 2024-03-31 | 1.44 |
| 2023-09-30 | 2.43 |
| 2023-03-31 | 2.14 |
| 2022-09-30 | 3.00 |
| 2022-03-31 | 4.73 |
| 2021-09-30 | 4.28 |
| 2021-03-31 | 3.43 |
| 2020-09-30 | 2.67 |
| 2020-03-31 | 1.75 |
| 2019-09-30 | 1.76 |
| 2019-03-31 | 0.00 |
| 2018-09-30 | 0.75 |
| 2018-03-31 | 0.00 |
